beta

ABBV

AbbVie, Inc.

Abbv

Chart

Stats

Earnings

News

Splits

Dividends

Earnings

Actual EPS
Consensus EPS
Estimated EPS
Number of Estimates
EPS Surprise

Stats

Summary

AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. It focuses on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology and dermatology; oncology, including blood cancers; virology, including hepatitis C virus (HCV) and human immunodeficiency virus (HIV); neurological disorders, such as as well as Parkinson's disease; metabolic diseases, comprising thyroid disease and complications associated with cystic fibrosis; pain associated with endometriosis; and other serious health conditions. The company was founded on October 19, 2011 and is headquartered in North Chicago, IL.

Market Cap: 131 Billion

Primary Exchange: New York Stock Exchange

Website: http://www.abbvie.com

Shares Outstanding: 1.48 Billion

Float: 1.48 Billion

Dividend: 4.28 (0.05%)

Beta: 0.873805321075863

Sector: Health Technology

Industry: Pharmaceuticals: Major

Ethical Flags

Animal testing

Longest drawdown: 488 trading days

From: 2018-01-26 To: 2019-12-12

Lowest Point:

Akero Therapeutics Readies $75 Million IPO

via: SeekingAlpha at 2019-06-13 09:11:26:000

Quick Take Akero Therapeutics ( AKRO ) has filed to raise gross proceeds of $75.0 million from a U.S. IPO, according to an S-1/A registration statement . The firm is developing a treatment for metabolic diseases with high unmet clinical needs, with an initial focus on non-alcoholic steato… read more...

Prevail Therapeutics Proposes IPO Terms

via: SeekingAlpha at 2019-06-13 07:46:25:000

Quick Take Prevail Therapeutics ( PRVL ) has filed to raise gross proceeds of $125 million from a U.S. IPO, according to an S-1/A registration statement . The firm is developing Adeno-Associated Virus-based [AAV-based] gene therapies for the treatment of serious neurodegenerative diseases… read more...

Bunker Dividend Growth Portfolio: Our 17th Dividend Aristocrat

via: SeekingAlpha at 2019-06-13 01:30:25:000

(Source: imgflip ) Note that to avoid reader confusion, I've shifted to a rotating portfolio update schedule. I'll now be providing just one update per week, alternating between my retirement portfolio (where I keep 100% of my life savings), and this model portfolio made up entirely of … read more...

June 2019 Stock Considerations

via: SeekingAlpha at 2019-06-12 23:24:27:000

After a wild May we seem to be trending back up in June. Of course, anyone in the DGI space already knows that these daily, weekly and monthly swings really don't matter to anyone with a very long-term time horizon. All we can do in the meantime is watch the market swing, stay in the game, fin… read more...

New Long-Term Data from Upadacitinib Phase 3 Studies in Rheumatoid Arthritis Including Results on Clinical Remission at 48 Weeks Presented at EULAR

via: PR Newswire at 2019-06-12 14:00:00:000

NORTH CHICAGO, Ill. , June 12, 2019 /PRNewswire/ -- AbbVie (NYSE: ABBV), a research-based global biopharmaceutical company, today announced new results from the Phase 3 clinical trials SELECT-EARLY and SELECT-COMPARE showing that patients receiving upadacitinib once-daily (15 mg or 30 mg,… read more...

AbbVie Inc. (ABBV) Management Presents at Goldman Sachs Global Healthcare Conference (Transcript)

via: SeekingAlpha at 2019-06-12 13:20:53:000

AbbVie Inc. (ABBV) Goldman Sachs Global Healthcare Conference June 12, 2019 11:00 AM ET Company Participants Mike Severino - Vice Chairman & President Rob Michael - Senior Vice President & CFO Conference Call Participants Terence C. Flynn - Goldman Sachs Presentati… read more...

Bert's May Dividend Income Summary

via: SeekingAlpha at 2019-06-12 05:44:02:000

Lanny said it best in his stock purchase article the month of May was actually wild! Every day presented a new twist, turn, and market swing. I would transfer cash to my brokerage and get ready to make a purchase. Then boom, the market would swing upward. Despite the madness, the div… read more...

Dividend Update - May 2019

via: SeekingAlpha at 2019-06-12 04:08:04:000

It has been a really busy year so far, and May was no different. You have probably noticed, I haven't been as active lately writing posts or buying stock. The main reason for this is because I just bought a house! So, I have basically just been saving all my capital to go toward that. Once thi… read more...

The Crazy Stuff That Happens To A Stock Portfolio

via: SeekingAlpha at 2019-06-12 01:09:46:000

It seems that every few months I get a portfolio shocker. There's often big news surrounding the individual stocks. I'll admit that I do not watch my holdings all that closely, but I certainly get all of the news feeds of my portfolio holdings courtesy of my Seeking Alpha home page. Yesterda… read more...

AbbVie's Skyrizi shows durable effect in late-stage psoriasis study; shares up 2%

via: SeekingAlpha at 2019-06-11 07:12:05:000

Two-year data from a Phase 3 clinical trial, IMMhance , evaluating AbbVie ( ABBV +2.3% ) and collaboration partner Boehringer Ingelheim's SKYRIZI (risankizumab) in adult patients with moderate-to-severe plaque psoriasis showed a sustained treatment benefit. The results are being presen… read more...

New Two-Year Data at the 24th World Congress of Dermatology Shows SKYRIZI(TM) (risankizumab) Maintains Complete Skin Clearance

via: PR Newswire at 2019-06-11 03:00:00:000

NORTH CHICAGO, Ill. , June 11, 2019 /PRNewswire/ --AbbVie (NYSE: ABBV), a research-based global biopharmaceutical company, today announced new results showing a significant number of patients treated with SKYRIZI (risankizumab) experienced complete skin clearance at week 94…. read more...

The Best Dividend Stocks To Buy During This Strong Market Rally

via: SeekingAlpha at 2019-06-11 01:13:43:000

(Source: imgflip ) Due to reader requests, I've decided to break up my weekly "Best Dividend Stocks To Buy This Week" series into two parts. One will be the weekly watch list article (with the best ideas for new money at any given time). The other will be a portfolio update. To also… read more...

How To Find Undervalued Stocks In The Healthcare Sector

via: SeekingAlpha at 2019-06-10 12:10:41:000

The healthcare sector is underperforming the market by a wide margin on a year to date basis. The Healthcare Select Sector ETF ( XLV ) has gained 5.2%, while the SPDR S&P 500 ( SPY ) is up by almost three times that, with a cumulative gain of 15.1% in the same period. Data by YCharts … read more...

Dividend Stock Watch List - June 2019

via: SeekingAlpha at 2019-06-09 05:13:37:000

Hey, everyone. It's time once again to start thinking about where we are going to deploy some funds this month. As I mentioned in last month's dividend stock watch list, I'm going to focus on our four lowest sectors each month. This way, we stay nice and diversified and don't have a sector… read more...

Chewy IPO, Lululemon And Tesla On Tap (Stocks To Watch Podcast)

via: SeekingAlpha at 2019-06-09 03:30:00:000

Our weekend preview of upcoming IPOs, earnings reports, conference presentations, investor days, IPO lockup expirations, FDA decisions, Barron's mentions and other key events that could impact stocks.. If you are interested in listening to Stocks To Watch to start your Sunday (you can r… read more...

Ex-Date Payment Date Record Date Declared Date Amount Flag Dividend Type Qualified Indicated
2020-01-14 2020-02-14 2020-01-15 2019-11-01 1.18 Cash
2019-10-11 2019-11-15 2019-10-15 2019-09-06 1.07 Cash
2019-10-11 2019-11-15 2019-10-15 2019-09-06 1.07 Cash
2019-10-11 2019-11-15 2019-10-15 2019-09-06 1.07 Cash
2019-10-11 2019-11-15 2019-10-15 2019-09-06 1.07 Cash
2019-10-11 2019-11-15 2019-10-15 2019-09-06 1.07 Cash
2019-10-11 2019-11-15 2019-10-15 2019-09-06 1.07 Cash
2019-10-14 2019-11-15 2019-10-15 2019-09-06 1.07 No Change QoQ
2019-07-12 2019-08-15 2019-07-15 2019-06-20 1.07 No Change QoQ
2019-04-12 2019-05-15 2019-04-15 2019-02-21 1.07 No Change QoQ
2019-01-14 2019-02-15 2019-01-15 2018-11-02 1.07 Increase
2018-10-12 2018-11-15 2018-10-15 2018-09-07 0.96 No Change QoQ
2018-07-12 2018-08-15 2018-07-13 2018-06-14 0.96 No Change QoQ
2018-04-12 2018-05-15 2018-04-13 2018-02-15 0.96 Increase
2018-01-11 2018-02-15 2018-01-12 2017-10-27 0.71 Increase
2017-10-12 2017-11-15 2017-10-13 2017-09-08 0.64 No Change QoQ
2017-07-12 2017-08-15 2017-07-14 2017-06-22 0.64 No Change QoQ
2017-04-11 2017-05-15 2017-04-13 2017-02-16 0.64 No Change QoQ
2017-01-11 2017-02-15 2017-01-13 2016-10-28 0.64 Increase
2016-10-12 2016-11-15 2016-10-14 2016-09-09 0.57 No Change QoQ
2016-07-13 2016-08-15 2016-07-15 2016-06-16 0.57 No Change QoQ
2016-04-13 2016-05-16 2016-04-15 2016-02-18 0.57 No Change QoQ
2016-01-13 2016-02-16 2016-01-15 2015-10-30 0.57 Increase
2015-10-13 2015-11-14 2015-10-15 2015-09-11 0.51 No Change QoQ
2015-07-13 2015-08-14 2015-07-15 2015-06-18 0.51 No Change QoQ
2015-04-13 2015-05-15 2015-04-15 2015-02-19 0.51 Increase
2015-01-13 2015-02-13 2015-01-15 2014-10-20 0.49 Increase
2014-10-13 2014-11-17 2014-10-15 2014-09-19 0.42 No Change QoQ
Ex-Date Declared Date Record Date Payment Date Ratio To Factor For Factor
Data provided by IEX Cloud